UCSF study finds a better way to screen for breast cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 4-Apr-2026 13:15 ET (4-Apr-2026 17:15 GMT/UTC)
If mistletoe’s status as a nutrient-stealing freeloader has been cooling your holiday ardor, new research led by an Oregon State University scientist may help relight the fire.
Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor-specific colonization, immune activation, and controllable therapeutic delivery. This review summarizes recent advances in the design and application of synthetic biological strategies that enhance bacterial precision, safety, and efficacy in tumor therapy. These strategies are categorized into three major regulatory modes: exogenous input–responsive gene circuits, autonomous bacterial signal–responsive gene circuits, and tumor microenvironment-responsive gene circuits.